Novel insights into STAT3 in renal diseases

Biomed Pharmacother. 2023 Sep:165:115166. doi: 10.1016/j.biopha.2023.115166. Epub 2023 Jul 18.


Signal transducer and activator of transcription 3 (STAT3) is a cell-signal transcription factor that has attracted considerable attention in recent years. The stimulation of cytokines and growth factors can result in the transcription of a wide range of genes that are crucial for several cellular biological processes involved in pro- and anti-inflammatory responses. STAT3 has attracted considerable interest as a result of a recent upsurge in study because of their role in directing the innate immune response and sustaining inflammatory pathways, which is a key feature in the pathogenesis of many diseases, including renal disorders. Several pathological conditions which may involve STAT3 include diabetic nephropathy, acute kidney injury, lupus nephritis, polycystic kidney disease, and renal cell carcinoma. STAT3 is expressed in various renal tissues under these pathological conditions. To better understand the role of STAT3 in the kidney and provide a theoretical foundation for STAT3-targeted therapy for renal disorders, this review covers the current work on the activities of STAT3 and its mechanisms in the pathophysiological processes of various types of renal diseases.

Keywords: AKI; DN; Post-translational modifications; Renal diseases; STAT3.

Publication types

  • Review

MeSH terms

  • Carcinoma, Renal Cell* / pathology
  • Humans
  • Kidney / pathology
  • Kidney Neoplasms* / pathology
  • Lupus Nephritis* / metabolism
  • STAT3 Transcription Factor / metabolism


  • STAT3 Transcription Factor
  • STAT3 protein, human